Applied molecular genetics and biology - IMG
Project goals
The objective of this project is to establish, at the Institute of Molecular Genetics of the AS CR, v. v. i. (IMG), an infrastructure for effective transfer of new research and development (R&D) results, based on public resources, into practical applications. The project also aims supporting closer cooperation of IMG with commercial companies and providing a continuous source of R&D outputs at IMG, resulting in innovations with commercialization potential. Objective of the project is to strengthen economic performance of the Institute and installation of self-support system for financing of proof-of-concept verification efforts after termination of the project.
Keywords
biotechnologymonoclonal antibodiesrecombinant proteinsaptamersdiagnostic sets, virostaticsgenetic manipulationsapplied chemical geneticscommercialization of research and developmentproof-of-conceptcommercialization system
Public support
Provider
Technology Agency of the Czech Republic
Programme
Programme of applied research, experimental development and innovations GAMA
Call for proposals
GAMA 1 (STA02014GA)
Main participants
Ústav molekulární genetiky AV ČR, v. v. i.
Contest type
VS - Public tender
Contract ID
ZP 1
Alternative language
Project name in Czech
Aplikovaná molekulární genetika a biologie - ÚMG
Annotation in Czech
Cílem tohoto projektu je vytvořit na Ústavu molekulární genetiky AV ČR, v.v.i. (ÚMG) infrastrukturu pro efektivní transfer nových poznatků VaV, vzniklých z veřejných zdrojů, do praktických aplikací. Cílem je rovněž etablování cest užší spolupráce pracovišť ÚMG s podniky a zajištění kontinuální tvorby výsledků VaV na ÚMG vedoucích k inovacím s potenciálem jejich komercializace. Jedná se především o ověření aplikačního potenciálu nových výsledků VaV před jejich možným využitím v praxi (tzv. „proof-of-concept stage“). Cílem projektu je posílit ekonomickou výkonnost ústavu a zavedení systému soběstačnosti při financování „proof-of-concept“ projektů po skončení tohoto projektu.
Scientific branches
R&D category
AP - Applied research
CEP classification - main branch
EB - Genetics and molecular biology
CEP - secondary branch
EI - Biotechnology and bionics
CEP - another secondary branch
CE - Biochemistry
10603 - Genetics and heredity (medical genetics to be 3)
10604 - Reproductive biology (medical aspects to be 3)
10605 - Developmental biology
10608 - Biochemistry and molecular biology
10609 - Biochemical research methods
20801 - Environmental biotechnology
20802 - Bioremediation, diagnostic biotechnologies (DNA chips and biosensing devices) in environmental management
20803 - Environmental biotechnology related ethics
20901 - Industrial biotechnology
20902 - Bioprocessing technologies (industrial processes relying on biological agents to drive the process) biocatalysis, fermentation
20903 - Bioproducts (products that are manufactured using biological material as feedstock) biomaterials, bioplastics, biofuels, bioderived bulk and fine chemicals, bio-derived novel materials
30101 - Human genetics
30401 - Health-related biotechnology
30402 - Technologies involving the manipulation of cells, tissues, organs or the whole organism (assisted reproduction)
30403 - Technologies involving identifying the functioning of DNA, proteins and enzymes and how they influence the onset of disease and maintenance of well-being (gene-based diagnostics and therapeutic interventions [pharmacogenomics, gene-based therapeutics])
30404 - Biomaterials (as related to medical implants, devices, sensors)
30405 - Medical biotechnology related ethics
40401 - Agricultural biotechnology and food biotechnology
40402 - GM technology (crops and livestock), livestock cloning, marker assisted selection, diagnostics (DNA chips and biosensing devices for the early/accurate detection of diseases) biomass feedstock production technologies, biopharming
40403 - Agricultural biotechnology related ethics
Completed project evaluation
Provider evaluation
U - Uspěl podle zadání (s publikovanými či patentovanými výsledky atd.)
Project results evaluation
These are preliminary data, the project evaluation hasn´t proceeded yet.
Solution timeline
Realization period - beginning
Jul 1, 2014
Realization period - end
Jun 30, 2019
Project status
U - Finished project
Latest support payment
Feb 28, 2019
Data delivery to CEP
Confidentiality
C - Předmět řešení projektu podléhá obchodnímu tajemství (§ 504 Občanského zákoníku), ale název projektu, cíle projektu a u ukončeného nebo zastaveného projektu zhodnocení výsledku řešení projektu (údaje P03, P04, P15, P19, P29, PN8) dodané do CEP, jsou upraveny tak, aby byly zveřejnitelné.
Data delivery code
CEP20-TA0-TG-U/07:1
Data delivery date
Feb 20, 2020
Finance
Total approved costs
20,800 thou. CZK
Public financial support
20,800 thou. CZK
Other public sources
0 thou. CZK
Non public and foreign sources
0 thou. CZK
Basic information
Recognised costs
20 800 CZK thou.
Public support
20 800 CZK thou.
100%
Provider
Technology Agency of the Czech Republic
CEP
EB - Genetics and molecular biology
Solution period
01. 07. 2014 - 30. 06. 2019